Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Víctor González-Rumayor"'
Autor:
Estela Sánchez‐Herrero, Roberto Serna‐Blasco, Vadym Ivanchuk, Rosario García‐Campelo, Manuel Dómine Gómez, José M. Sánchez, Bartomeu Massutí, Noemi Reguart, Carlos Camps, Sandra Sanz‐Moreno, Silvia Calabuig‐Fariñas, Eloísa Jantus‐Lewintre, Magdalena Arnal, Dietmar Fernández‐Orth, Virginia Calvo, Víctor González‐Rumayor, Mariano Provencio, Atocha Romero
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2363-2376 (2021)
Despite impressive and durable responses, nonsmall cell lung cancer (NSCLC) patients treated with anaplastic lymphoma kinase (ALK) inhibitors (ALK‐Is) ultimately progress due to development of resistance. Here, we have evaluated the clinical utilit
Externí odkaz:
https://doaj.org/article/f8857d8e937348c0ac60929a958c48fe
Autor:
Gabriela Guzmán-Martínez, Concepción Marañón, CYTED RIBLES Network, Ana María Blasini, Víctor González-Rumayor, Roberto Muñoz-Louis, Bernardo A. Pons-Estel, Guillermo Pons-Estel, Rosana Quintana, Martín A. Rodríguez, Manuel F. Ugarte-Gil, Gloria Vásquez
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Systemic lupus erythematosus (SLE) patients display an increased risk of cardiovascular disease (CVD). With the improved clinical management of other classical severe manifestation of the disease, CVD is becoming one of the most relevant complication
Externí odkaz:
https://doaj.org/article/d6dde961fcaf4407a38b2a79dc8f70d7
Autor:
Jordi Martorell-Marugán, Raúl López-Domínguez, Adrián García-Moreno, Daniel Toro-Domínguez, Juan Antonio Villatoro-García, Guillermo Barturen, Adoración Martín-Gómez, Kevin Troule, Gonzalo Gómez-López, Fátima Al-Shahrour, Víctor González-Rumayor, María Peña-Chilet, Joaquín Dopazo, Julio Sáez-Rodríguez, Marta E. Alarcón-Riquelme, Pedro Carmona-Sáez
Publikováno v:
BMC Bioinformatics, Vol 22, Iss 1, Pp 1-14 (2021)
Abstract Background Autoimmune diseases are heterogeneous pathologies with difficult diagnosis and few therapeutic options. In the last decade, several omics studies have provided significant insights into the molecular mechanisms of these diseases.
Externí odkaz:
https://doaj.org/article/9d042e0eda33436597b7e2f20477a1c9
Autor:
Estela Sánchez-Herrero, Roberto Serna-Blasco, Lucia Robado de Lope, Víctor González-Rumayor, Atocha Romero, Mariano Provencio
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Cancer cells release nucleic acids, freely or associated with other structures such as vesicles into body fluids, including blood. Among these nucleic acids, circulating tumor DNA (ctDNA) has emerged as a minimally invasive biomarker for tumor molecu
Externí odkaz:
https://doaj.org/article/b2ecac58b9f245bb9ac91ce5a3cb6d2a
Autor:
Pere Puig, Nadina Erill, Marta Terricabras, Isaac Subirana, Judit González-García, Adrià Asensi-Puig, Michael J. Donovan, Lourdes Mengual, M. Teresa Agulló-Ortuño, Mireia Olivan, Antonio Alcaraz, José A. López-Martín, Inés de Torres, José Luis Rodríguez-Peralto, Alfredo Rodríguez-Antolín, Juan Morote, Víctor González-Rumayor
Publikováno v:
BMC Research Notes, Vol 12, Iss 1, Pp 1-5 (2019)
Abstract Objectives To apply a systems pathology-based approach to the quantification of nuclear Active β-catenin and human leukocyte antigen class I, and assess the biomarker involvement in a cohort of prostate tumor patients. Results The systems p
Externí odkaz:
https://doaj.org/article/4d405566776c46dc8eae9d4782501ce5
Autor:
Gorjana Rackov, Giorgia Iegiani, Daniel Uribe, Claudia Quezada, Cristóbal Belda-Iniesta, Carmen Escobedo-Lucea, Augusto Silva, Pere Puig, Víctor González-Rumayor, Ángel Ayuso-Sacido
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Glioblastoma (GBM) is the most devastating and least treatable brain tumor with median survival
Externí odkaz:
https://doaj.org/article/4135ff28564f4278b1bca53b8116c765
Autor:
Irina Palacín-Aliana, Noemí García-Romero, Adrià Asensi-Puig, Josefa Carrión-Navarro, Víctor González-Rumayor, Ángel Ayuso-Sacido
Publikováno v:
Biomedicines, Vol 9, Iss 8, p 906 (2021)
Cancer is one of the leading causes of death worldwide and remains a major public health challenge. The introduction of more sensitive and powerful technologies has permitted the appearance of new tumor-specific molecular aberrations with a significa
Externí odkaz:
https://doaj.org/article/5becb84bfb6646afaf1d743a0af06c37
Autor:
Estela Sánchez-Herrero, Carmen Campos-Silva, Yaiza Cáceres-Martell, Lucía Robado de Lope, Sandra Sanz-Moreno, Roberto Serna-Blasco, Alejandro Rodríguez-Festa, Dunixe Ares Trotta, Paloma Martín-Acosta, Cristina Patiño, María José Coronado, Alexandra Beneitez, Ricardo Jara, Nerea Lago-Baameiro, Tamara Camino, Alberto Cruz-Bermúdez, María Pardo, Víctor González-Rumayor, Mar Valés-Gómez, Mariano Provencio, Atocha Romero
Publikováno v:
Clinical Chemistry. 68:668-679
Background ALK rearrangements are present in 5% of nonsmall cell lung cancer (NSCLC) tumors and identify patients who can benefit from ALK inhibitors. ALK fusions testing using liquid biopsies, although challenging, can expand the therapeutic options
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b039b41355227d3aaac2305bfe5b8fa7
https://doi.org/10.1093/clinchem/hvac021
https://doi.org/10.1093/clinchem/hvac021
Autor:
Rosario García-Campelo, Magdalena Arnal, Virginia Calvo, Víctor González‐Rumayor, Eloisa Jantus-Lewintre, Estela Sánchez-Herrero, Noemi Reguart, Sandra Sanz-Moreno, Carlos Camps, Atocha Romero, Dietmar Fernández‐Orth, Mariano Provencio, Bartomeu Massuti, Roberto Serna-Blasco, Vadym Ivanchuk, Manuel Dómine Gomez, Silvia Calabuig-Fariñas, Jose Miguel Sanchez
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2363-2376 (2021)
Molecular Oncology
Molecular Oncology
Despite impressive and durable responses, nonsmall cell lung cancer (NSCLC) patients treated with anaplastic lymphoma kinase (ALK) inhibitors (ALK‐Is) ultimately progress due to development of resistance. Here, we have evaluated the clinical utilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4f267cb7cf510a38e86b00684c09443
https://doaj.org/article/f8857d8e937348c0ac60929a958c48fe
https://doaj.org/article/f8857d8e937348c0ac60929a958c48fe
Autor:
Pedro Carmona-Sáez, Joaquín Dopazo, Víctor González-Rumayor, Adoracion Martin-Gomez, Fatima Al-Shahrour, Gonzalo Gómez-López, Juan Antonio Villatoro-García, Maria Peña-Chilet, Julio Saez-Rodriguez, Guillermo Barturen, Marta E. Alarcón-Riquelme, Jordi Martorell-Marugán, Kevin Troulé, Adrian Garcia-Moreno, Daniel Toro-Domínguez, Raúl López-Domínguez
Publikováno v:
BMC Bioinformatics, Vol 22, Iss 1, Pp 1-14 (2021)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Digital.CSIC. Repositorio Institucional del CSIC
BMC Bioinformatics
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Digital.CSIC. Repositorio Institucional del CSIC
BMC Bioinformatics
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
This work is partially funded by FEDER/Junta de Andalucia-Consejeria de Economia y Conocimiento (Grant CV20-36723), Consejeria de Salud (Grant PI-0173-2017) and by EU/EFPIA Innovative Medicines Initiative Joint Undertaking PRECISESADS (115565). JMM i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24f928b0c2a2d06319a7a191667fe457
https://doaj.org/article/9d042e0eda33436597b7e2f20477a1c9
https://doaj.org/article/9d042e0eda33436597b7e2f20477a1c9